发明授权
- 专利标题: Crystal forms of oxcarbazepine and processes for their preparation
- 专利标题(中): 奥卡西平的晶体形式及其制备方法
-
申请号: US10074181申请日: 2002-02-12
-
公开(公告)号: US07183272B2公开(公告)日: 2007-02-27
- 发明人: Judith Aronhime , Ben-Zion Dolitzky , Yana Berkovich , Nissim Garti
- 申请人: Judith Aronhime , Ben-Zion Dolitzky , Yana Berkovich , Nissim Garti
- 申请人地址: IL Petah Tiqva
- 专利权人: Teva Pharmaceutical Industries Ltd.
- 当前专利权人: Teva Pharmaceutical Industries Ltd.
- 当前专利权人地址: IL Petah Tiqva
- 代理机构: Kenyon & Kenyon LLP
- 主分类号: A61P25/16
- IPC分类号: A61P25/16 ; A61P25/08 ; A61K31/55 ; C07D223/18
摘要:
The present invention provides for new crystal forms of oxcarbazepine, more particularly oxcarbazepine Forms B, C, D and E. The present invention further provides processes for preparation of these forms. Form B is prepared by evaporating the solvents from a solution of oxcarbazepine in toluene and dichloromethane. Form B is also obtained by immediately cooling the solution of oxcarbazepine and toluene. Cooling the same solution at a slower rate, but still fairly rapidly, results in oxcarbazepine Form C. Cooling the same solution at even a slower rate results in another Form, oxcarbazepine Form D. Oxcarbazepine Form E, a solvate of chloroform, is obtained by precipitating a solution of oxcarbazepine and chloroform. The present invention also provides processes for converting one of the newly discovered crystal forms of oxcarbazepine into another crystal form, including Form A, which is in the prior art. These conversions may occur by storage at ambient temperature, by heating one particular Form or treatment with a protic solvent.
公开/授权文献
信息查询